Adaptive Biotechnologies Corporation
ADPT
$12.63
$0.3352.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 12.27% | 10.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.27% | 10.50% | |||
| Cost of Revenue | 148.15% | 138.04% | |||
| Gross Profit | -52.78% | -61.49% | |||
| SG&A Expenses | 2.26% | 2.06% | |||
| Depreciation & Amortization | 0.95% | -2.10% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.28% | 0.92% | |||
| Operating Income | 15.43% | 12.51% | |||
| Income Before Tax | 14.20% | 11.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.20% | 11.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 4.55% | -188.00% | |||
| Net Income | 14.20% | 11.40% | |||
| EBIT | 15.43% | 12.51% | |||
| EBITDA | 17.44% | 15.37% | |||
| EPS Basic | 15.84% | 12.28% | |||
| Normalized Basic EPS | 18.44% | 13.18% | |||
| EPS Diluted | 15.84% | 12.28% | |||
| Normalized Diluted EPS | 18.44% | 13.18% | |||
| Average Basic Shares Outstanding | 1.94% | 1.03% | |||
| Average Diluted Shares Outstanding | 1.94% | 1.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||